Smart Pills Patient Monitoring Market Trends

  • Report ID: 3864
  • Published Date: Jul 24, 2024
  • Report Format: PDF, PPT

Smart Pills Patient Monitoring Market Trends

Growth Drivers

  • Growing Prevalence of Gastrointestinal Reflux Disease (GERD) – Gastrointestinal reflux disease (GERD) happens when stomach acid rushes back into the tube that connects the mouth and stomach. Acid reflux (backwash) can irritate the lining of the esophagus. Several individuals suffer from acid reflux periodically. Acid reflux can lead to GERD if it develops frequently over time. Thus, the surging rate of GERD is anticipated to drive the smart pills patient monitoring market during the projected time frame. For instance, gastrointestinal reflux disease (GERD), commonly known as chronic acid reflux, affects approximately 25% of the population in the United States.

  • Rising Stances of Missed Medication Doses – Elderly population along with patients suffering from neurological disorders are more prone to miss their medication doses. Such stances are more common in those people who are either very old or suffering from disorders such as Alzheimer’s and dementia. Smart pills are extremely beneficial in properly monitoring the medication doses at a determined time. Therefore, such an increase in missed medication doses is estimated to further boost the market growth of smart pills patient monitoring over the projected time frame throughout the forecast period. For instance, as per a study, in the United States, approximately 40% of individuals missed numerous doses of their medications as they simply forgot to take them, while 20% neglected to update their prescriptions on time, and 10% delayed refills. Whereas, nearly 42 to 65% of mentally ill individuals have poor medication adherence and occasionally take their medicines on time.

  • Worldwide Increase in Neurological Disorders – Based on a report, almost 7 million people worldwide die from neurological conditions each year.

  • Rising Technological Innovation and Success Rate of Capsule Endoscopy - Endoscopy is the straight insertion of a long, thin tube into the body to examine an internal organ such as the gastrointestinal tract. Endoscopies are minimally invasive procedures that use bodily openings such as the mouth or anus. Moreover, the small bowel which is mostly an enigmatic and inaccessible portion of the GI system can now be reached with the help of next level endoscopic device such as capsule endoscopy procedures. Hence, the increasing technological innovation and success ratio of capsule endoscopy are also estimated to push the market growth further throughout the projected time frame. For instance, colon capsule endoscopy (CCE) has a high rate of success around 65% to 98% in patients who had incomplete colonoscopy owing to the intense pain, significant mesenteric redundancy, and postoperative adhesions.

  • Globally Surging Prevalence of COVID-19 – As per the World Health Organization statistics, there have been 756,581,850 confirmed cases of COVID-19 worldwide as of February 2023, along with 6,844,267 mortalities.

Challenges

  • High Cost of Smart Pills – Smart pills patient monitoring is quite effective yet its price is higher as compared to the conventional pills. Since the hefty price associated with these pills, hence the use of such pills by a major mass is not much possible. Thus, this factor is anticipated to lower the growth of the market in the coming years.
  • Stringent Government Regulations about the Use of Smart Pills
  • Technical Incompetence of Smart Pills in Some Disorders

Smart Pills Patient Monitoring Market: Key Insights

Base Year

2023

Forecast Year

2024-2036

CAGR

15.9%

Base Year Market Size (2023)

USD 5.8 Billion

Forecast Year Market Size (2036)

USD 39.46 Billion

Regional Scope

  • North America (U.S., and Canada)
  • Latin America (Mexico, Argentina, Rest of Latin America)
  • Asia-Pacific (Japan, China, India, Indonesia, Malaysia, Australia, Rest of Asia-Pacific)
  • Europe (U.K., Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe)
  • Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa)
Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 3864
  • Published Date: Jul 24, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2024, the industry size of smart pills patient monitoring is evaluated at USD 6.63 Billion.

The smart pills patient monitoring market size was over USD 5.8 Billion in 2023 and is expected to exceed USD 39.46 Billion by the end of 2036, witnessing over 15.9% CAGR during the forecast period i.e., between 2024-2036. Increasing ratio of various types of chronic disorders, rising prevalence of gastrointestinal reflux disease (GERD), and worldwide increase in neurological disorders are the major factors driving the market growth.

North America is likely to dominate majority industry share by 2036, attributed to higher frequency of colorectal cancer amongst people, driven by rise in sedentary lifestyles, and rapidly surging ratio of geriatric populace in the region.

Medtronic plc, AbbVie Inc., Novartis AG, CapsoVision, Inc., Medimetrics, SA de CV, TauRx Pharmaceuticals Ltd, Otsuka Pharmaceutical Co. Ltd., FUJIFILM Holdings Corporation,
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample